HouseH.R. 9632119th Congress
To better coordinate Federal efforts to utilize advance technologies, such as AI, to improve diagnoses, treatments, cures, and prevention strategies for pediatric cancer, and for other purposes.
Full Text
Official text as published. Use Ctrl+F / Cmd+F to search within the document.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9632 Introduced in House (IH)]
<DOC>
119th CONGRESS
2d Session
H. R. 9632
To better coordinate Federal efforts to utilize advance technologies,
such as AI, to improve diagnoses, treatments, cures, and prevention
strategies for pediatric cancer, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
July 9, 2026
Mr. McCaul (for himself, Mr. Bera, and Mr. Kelly of Pennsylvania)
introduced the following bill; which was referred to the Committee on
Energy and Commerce
_______________________________________________________________________
A BILL
To better coordinate Federal efforts to utilize advance technologies,
such as AI, to improve diagnoses, treatments, cures, and prevention
strategies for pediatric cancer, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Accelerating Innovation (AI) for
Kids with Cancer Act''.
SEC. 2. HARNESSING UNITED STATES AI INNOVATION TO TREAT AND CURE
PEDIATRIC CANCER.
(a) In General.--The President, in consultation with the Secretary
of Health and Human Services (in this section referred to as the
``Secretary''), shall appoint an individual or entity to serve as the
coordinator of Federal efforts to utilize advance technologies, such as
AI, to improve diagnoses, treatments, cures, and prevention strategies
for pediatric cancer. Such individual or entity shall be known as the
Coordinator of AI Innovation (in this section referred to as the
``Coordinator''). The Coordinator shall serve as a member of the
Domestic Policy Council.
(b) Identification of CCDI Opportunities.--In carrying out
subsection (a), the Coordinator shall identify opportunities to
accelerate the progress of AI-driven solutions at the Childhood Cancer
Data Initiative (in this section referred to as the ``CCDI''),
including--
(1) by improving clinical trial design and access through
incorporating AI approaches;
(2) by making data platforms and tools available as part of
the CCDI Data Ecosystem;
(3) by improving data infrastructure through consolidating
data from multiple sources for AI-ready analysis and through
utilizing AI to better select participants for clinical trials;
(4) by enhancing data analysis through integration with AI
tools--
(A) to improve predictive modeling of patient
response, disease progression, and treatment toxicity;
and
(B) to turn multi-omics data and imaging data into
novel diagnostic, prognostic, and therapeutic
biomarkers; and
(5) by improving clinical trial design, access, and
outcomes for patients by incorporating multimodal data and
using AI approaches.
(c) Improving Data Sharing and Empowering Patients.--
(1) Integration of ai innovation into current work on
interoperability.--The Secretary shall work to ensure that AI
innovation is appropriately integrated into current work on
interoperability to maximize the potential for electronic
health records and claims data to inform private sector and
academic research and clinical trial design, while ensuring
that individuals (or authorized representatives) control their
health information.
(2) Interoperability standards for patient data to be used
with ai.--The Secretary shall work to finalize interoperability
standards for patient data to be used with AI that--
(A) appropriately account for structured and
unstructured data; and
(B) enable safe and privacy-compliant exchanges of
data.
(d) Report.--Not later than 180 days after the date of the
enactment of this Act, the Secretary shall submit to the appropriate
committees of Congress a report on the implementation of this section.
(e) Definitions.--In this section:
(1) Artificial intelligence; ai.--The terms ``artificial
intelligence'' and ``AI'' have the meaning given the term
``artificial intelligence'' in section 5002 of the National
Artificial Intelligence Initiative of 2020 (15 U.S.C. 9401).
(2) Appropriate committees of congress.--The term
``appropriate committees of Congress'' means--
(A) the Committee on Energy and Commerce of the
House of Representatives;
(B) the Committee on Science, Space, and Technology
of the House of Representatives;
(C) the Committee on Health, Education, Labor, and
Pensions of the Senate; and
(D) the Committee on Commerce, Science, and
Transportation of the Senate.
(f) Authorization of Appropriations.--
(1) In general.--There are authorized to be appropriated to
carry out this section such funds as may be necessary for each
of fiscal years 2027 through 2031.
(2) CCDI.--In addition to amounts made available to carry
out this section under paragraph (1) for a fiscal year, there
is authorized to be appropriated to carry out subsection (b),
$100,000,000 for each of fiscal years 2027 through 2031.
<all>